CME vs CBOE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Feb 01, 2026

CME

64.8
AI Score
VS
CME Wins

CBOE

63.3
AI Score

Investment Advisor Scores

CME

Feb 01, 2026
65score
Recommendation
BUY

CBOE

Feb 01, 2026
63score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CME CBOE Winner
Forward P/E 22.779 25.8398 CME
PEG Ratio 5.589 2.7682 CBOE
Revenue Growth -3.0% 8.1% CBOE
Earnings Growth -0.4% 37.7% CBOE
Tradestie Score 64.8/100 63.3/100 CME
Profit Margin 59.0% 21.3% CME
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.